Aurobindo Pharma launches TheraNym, India’s largest biologics CMO

MSD joins as anchor customer as Aurobindo strengthens its position in the fast-growing global biologics manufacturing market

Wanbury FY26 PAT surges 117% to Rs. 66.1 crore

Teva expands European biosimilars push with AHZANTIVE launch for eye disease treatment

Teva said the launch strengthens its biosimilars strategy and expands access to biologic medicines across Europe

Omnix Medical advances first-in-class antimicrobial OMN6 into Phase II trials

Targeting deadly drug-resistant acinetobacter infections

Muthukumar Anbalagan joins Intas Pharma as General Manager – NDDS

Anbalagan has led end-to-end product development programs from concept to commercialization, with a strong focus on regulatory compliance, process scalability, and manufacturing readiness

HeartBeam study shows pocket-sized ECG device can predict heart attack risk

Highlights potential for at-home heart attack risk assessment, offering a new approach to reducing treatment delays

Ipca Laboratories appoints Dr. Sandarbh Rishi as Head – MSAT/Pilot Plant

Dr. Rishi brings more than 15 years of experience in bioprocess development, microbial fermentation, technology transfer, and biotechnology operations

TDB supports Indigenous production of green pharma ingredients

Chennai based Bioneemtec India has received support from Technology Development Board for commercializing indigenous green chemistry technologies to produce critical pharmaceutical ingredients

ResMed acquires Noctrix Health for $340 million

Following the completion of the acquisition on June 3, Noctrix’s flagship product, Nidra will become part of ResMed’s broader sleep medicine portfolio

India’s medical devices sector is poised for a pharma-like transformation: Pranav Sharma, SBU Head - Advanced Surgery, Healthium MedTech

The industry is expected to grow significantly over the next few years as healthcare accessibility improves and insurance penetration increases